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The early growth response gene, Egr-l (NGFI-A, krox 24, 
zif 268, TIS 8), is a member of a family of genes with sug-
gested importance in the regulation of cell growth and dif-
ferentiation. Retinoic acid has been shown to markedly in-
duce Egr-l gene expression in mouse embryonal carcinoma 
cells and rat preosteoblastic cells. In this study we demon-
strate that treatment of cultured human skin fibroblasts with 
retinoic acid results in a rapid transient four-fold induction of 
Egr-1 transcripts, being maximum at 60 min and returning 
to a basal level by 120 min. However, treatment of cultured 
human keratinocytes with retinoic acid did not significantly 
induce Egr-l transcripts. Expression ofEgr-l message in ker-
atinocytes was observed to be induced by fetal bovine serum 
W hen eukaryotic cells are stimulated to undergo mitogenesis or differentiation, a small subset of genes, termed early-response or immedi-ate-early genes, are expressed. These genes contain several common features: induction 
occurs within minutes of cell stimulation, initiation of transcription 
does not require de /lOVO protein synthesis, and the gene products 
contain structural and functional properties common to transcrip-
tional regulatory proteins [1]. At present, these immediate-early 
transcription factors can be grouped into four major classes: the jun 
family (c-jun, jun-B, jun-D) [2-5], the fos family (c-fos, fra-l, 
fos-B) [6-8], a member of the steroid hormone receptor super fam-
ily (NGFI-B) {9,10], and the early growth response gene family 
(Egr-l,-2,-3,-4) [1 1-14]. Egr-1, also known as NGFI-A [15] , zif 
268 [16]. krox 24 [17], and TIS 8 [1 8], encodes a nuclear phospho-
protein containing three zinc finger motifs of the Cys2-His2 
subclass that bind specifically to the consensus sequence 5'-
GCGGGGGCG-3' as well as transactivate a promoter containing 
this sequence [19,20). The crystal structure of the three zinc fingers 
of Egr-l and its consensus binding site have recently been deter-
mined [21). 
Egr-l was originally cloned from mitogen-stimulated fibroblasts 
[1 2] . The gene is inducible by both growth-inhibitory and cell-
stimulatory cytokines in skin fibroblasts [22], and by retinoic acid 
(RA) in mouse P19 embryonal carcinoma cells [23] and rat preos-
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and tetra-decanoyl phorbol acetate, whereas calcium, 
1 ,25-dihydroxyvitamin D3 , and cyclic adenosine monophos-
phate caused little or no induction. Topical application of 
0.1 % retinoic acid cream in vivo resulted in a two- to threefold 
induction ofEgr-1 transcripts following treatment for 24 and 
48 h, returning to nearly basal levels by 96 h . Taken to-
gether, these data are consistent with the possibility that 
Egr-l is a proximal component of an intracellular molecular 
cascade that may give rise to alterations in cell phenotype in 
response to retinoic acid. Key words: retinoic acid/gene regula-
tiol1/jibroblasts/keratirlOcytes. ] Invest Dermatol 102:730- 733, 
1994 
teoblastic cells [24]. However, nothing is known about Egr-l gene 
expression in human skin. The main purpose of the present study 
was to examine the regulation of Egr-l gene expression by RA in 
cultured skin fibroblasts and keratinocytes, as well as in human skin, 
by Northern analysis. 
MATERIALS AND METHODS 
Cell Culture Human dermal fibroblast cultures were prepared from 
punch biopsies of buttock skin [25] and propagated in Dulbecco's modified 
Eagle's medium containing 10% fetal bovine serum (FBS), 100 U/ml of 
penicillin, and 100 J.lg/ml of streptomycin. Cells were then grown to con-
fluency in 150-mm tissue culture dishes (Corning Glass Co., Corning, NY) 
and treated for various times with 1 J.lM RA (Fig 1). Human keratinocytes 
were purchased from Clonetics and expanded to about 50% confluency in 
150-mm tissue culture dishes in a low-Ca+ + (0.15 mM), serum-free kerati-
nocyte growth medium (KGM) containing epidermal growth factor (EGF) 
(O.lng/ml), insu lin (5 J.lg/ml), hydrocortisone (0.5J.lg/ml), bovine pituitary 
extract, gentamicin (50 J.lg/ml), and amphotericin-B (50 ng/ml) (Clonetics, 
San Diego, CAl . In all cases, fresh media were added to cells at least 24 h 
prior to stimuli. Cells were then treated up to 120 min with 1 J.lM retinoic 
acid (RA) (Fig 1) or for 60 min with calcium (2 mM), tetra-decanoyl phor-
bol acetate (TPA) (2 J.lM), FBS (10%), l,25-dihydroxyvitamin D3 (10 J.lM) , 
or cyclic adenosine monophosphate (cAMP) (50 J.lM) (Fig 2). Furthermore, 
for both fibroblasts and keratinocytes a time course ofRA (1 J.lM) treatment 
encompassing the ill villo times of treatment (24-48 h) was performed. 
Stock solutions ofRA, TPA, and l,25-dihydroxyvitamin D3 were diluted in 
ethanol, which was present in all treated and control cultures at a final 
concentration of 0.1 %. 
Cell growth was in a humidified incubator at 37"C with 5% CO2/95% 
air. When ce lls were treated with RA, they were protected from light during 
the incubation period. Experiments were conducted on cel ls in the third 
through sixth passage. 
Skin Biopsies For ill vil'o RA treatment, 0.05% or 0.1 % retinoic acid 
cream or its vehicle (Ortho Pharmaceuticals, Raritan, NJ) was applied once 
to skin and maintained under p1astic wrap for 4, 8, 16, 24, 48, or 96 h prior to 
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Figure 1. Kinetics of Egr-l mRNA induction by RA in human dermal 
fibroblasts (0) and in keratinocytes (e). Cell cultures were treated with 
1 11M RA at time 0, and individual cultures were harvested at the times 
indicated. Total RNA (20 J.lg per lalle) was hybridized against the cDNA 
probe for Egr-l. The data represent the average of two experiments. Indi-
vidual values from each experiment varied less than 15%. 
biop sy. After obtaining written informed consent, skin was removed at a 
depth of O.~ mm using a dermatome GB320 (Aesculap: Burlingame, CAl· 
Plain lidoca1l1e (1 %) was used as a local anesthetic. PrevIOUS work has dem-
onstrated that a single application, and subsequent occlusion, of 0.1 % RA 
cream for 4 d produces epidermal hyperplasia and thickened granular layer 
[26]. Thus, we examined 5-J.lm frozen sections fro m 4-d RA- and vehicle-
trea ted keratome biopsies by hematoxylin and eosin staining to assess their 
depth . We found that keratome biopsies from both k.inds of specimens 
contained full epldenms with some reSidual dernus. Epidermal keratomes 
were immediately frozen in liquid nitrogen and stored at - 70 ' C until use. 
All protocols for human subjects were preapproved by the University of 
Michigan Institutional Review Board. 
Northern Analysis of mRNA RNA was isolated from cultured human 
skin fibroblasts, keratinocytes or frozen keratome biopsies by guanidinium 
isothiocyanate lysis and ultracentrifugation as previously described [27). 
Briefly, RNA concentrations were determined by absorbance at 260 nm and 
equal quantities of total RNA were electrophoretically separated in 1 % 
formaldehyde-agarose gels containing 0.5 J.lg/ ml ethidium bromide. 
Twenty micrograms total RNA was transferred to derivatized nylon mem-
branes (Zeta-Probe; Bio-Rad, Richmond , CAl. Filters were baked for 2 h at 
80·C ill vaCllO, then prehybridized for 2-4 h at 42 'C in 50% formamide, 
5 X SSC (1 X SSC = 150 mM NaCl, 15 mM sodium citrate), 50 mM so-
dium phosphate, pH 7.0, 1 X Denhardt's solution, 250 ILg/ml yeast tRNA, 
100 J.Lg/ ml sonicated herring sperm DNA, and t % sodium dodecyl sulfate 
(SDS). Hybridiza tion was carried out for 18 h at 42 ' C in the same buffer. 
Blots were sequentia lly hybridized against 32P-labeled Egr-l (base pairs 
1-1990) [15) and cyclophilin [28) probes prepared by random priming. 
Quantitation of mRNA levels were performed using a phosphorimager 
(Molecular Dynamics, Sunnyvale, CA), and Egr-l message levels were nor-
malized to cyclophilin . Filters were washed once in 0.2 X SSC, 0.1 % SDS at 
room temperature, then twice for 15 min in 0.2 X SSC, 0.1 % SDS at 56 ' C, 
and finally once for 15 min in 0.1 X SSC, 0.1 % SDS, also at 56 'c. Autora-
diography was performed using intensifying screens at -70'C. 
Statistics For each duration of time (i .e., 16, 24, 48, and 96 h) , the fold 
induction was compared to unity by a one-sample t test. All p values are 
two-tailed. 
RESULTS 
Kinetics of Egr-1 mRNA Induction by RA in Human Der-
mal Fibroblasts and in Keratinocytes Human dermal fibro-
blas ts were treated w ith 1 11M RA for different times, as indicated in 
Fig 1. The stimulated cells were harvested, RNA extracted, and 
Egr-1 mRNA levels determined . Stimulation by RA resulted in a 
rapid increase ofEgr-1 mRNA, reaching a peak at 60 min (fourfold 
induction) and returning to a basal level within 120 min of treat-
ment. Induction of Egr-l expression by RA was also determined in 
ke ratinocytes. In these cells, only a slight increase (not statistical1y 
significant) in Egr-1 mRNA was observed at 60 min treatment (Fig 
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1). For both fibrobl asts and keratinocytes treatment with 1 11M RA 
up to 48 h did not show any further induction ofEgr-1 mRNA. In 
both untreated fibroblasts and keratinocytes, Egr-1 mRNA was at a 
low but detectabl e level. 
Induction of Egr-1 mRNA in Human Cultured Keratino-
cytes by Agents other than RA Subconfluent cultures ofkerati-
nocytes were incubated with calcium, FCS, TP A, 1,25-dihydroxy-
vitamin D 3 , or cAMP for 60 min at the concentrations indicated 
(Fig 2). FCS and TPA treatment resulted in an approximately five-
to sixfold induction of Egr-1 transcripts, w hereas calcium, 1,25-
dihydroxyvitamin D 3 , and cAMP caused li ttle or no Egr-1 mRNA 
induction. 
Expression ofEgr-1 mRNA in Human Skin In V ivo Egr-1 
transcripts were detectable in untreated skin (data not shown) as 
well as in skin treated w ith vehicle (Fig 3b). RA (0.1 %) trea tment 
for 4 and 8 h did not induce Egr-1 mRNA (data not shown) , 
whereas a slight but insignificant induction was observed after 16 h 
(mean 1.38 times ± 0.24 SEM, P = 0 .215). Following 0.1 % RA 
treatment for 24 h (mean 2.26 times ± 0 .17 SEM, P = 0.0007) and 
48 h (mean 2.43 times ± 0.28 SEM , P = 0.0038) , Egr-1 transcripts 
were significantly induced, compared to vehicle-treated skin and 
returned to a nearly basal level within 96 h (mean 1.30 times ± 0 .14 
SEM, P = 0 .05) of treatment (Fig 3a,b). Induction ofEgr-1 mRNA 
w as also observed at 24 and 48 h after treatment with 0.05% RA 
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Figure 3. aJ Induction of Egr-l mRNA in human skin by topically applied 
RA. Each vol unteer was treated with RA (0.1 %) or its vehicle for the times 
indicated prior to biopsy. Keratome biopsies were obtained and RNA ex-
tracted as described in Materials alld Methods. Data arc expressed as fold 
induction ± SEM, relative to vehicle-treated skin. N is the number of RA-
treated patients obtained at each time point. b J Autoradiographic bands from 
three representative experiments following treatment for 24,48, and 96 h. A 
plus sigll denotes RA-treated skin, whereas a millus sign indicates skin treated 
with vehicle alone. Blots were hybridized to a cycloph ilin control gene, 
which showed insignificant loading differences (resul ts not shown). 
cream. The levels of Egr-1 mRNA induction by 0 .05% RA cream 
were similar to those observed with 0.1 % RA cream. 
DISCUSSION 
This study demonstrates that Egr-l is expressed in human skin ill 
villo and that this gene can be upregulated by a RA treatment in skin 
and in cultured skin fibroblasts but not in keratinocytes il1 vitro. The 
Egr-l transcripts following RA stimulation in fibroblasts are tran-
sient, wnich corroborates earlier findings in murine P19 embryonal 
carcinoma cells [23] and rat preosteoblastic cells [24]. 
Serum response element (SRE)-like sequences of the murine 
Egr-l gene have been found to be functional in fibroblasts stimu-
lated by serum, platelet-derived growth factor, fibroblast growth 
factor, and TPA [19,29]. Recently, sequencing of the 5' flanking 
region of the human Egr-1 gene identified five serum response-like 
elements, two cAMP response-like elements, an Egr- l binding site, 
and a TPA-responsive element all within 700 nucleotides in the 
upstream region [30]. It was demonstrated that a 500-base pair frag-
ment, including several of these possible regulatory sequences, is 
functional and responsive to TPA in transient transfection assays. 
However, the cAMP response-like elements have not been shown 
to be functional. In accordance with these observations, we ob-
served a marked increase of Egr-l message in keratinocytes by both 
FCS and TPA, whereas cAMP, calcium, and 1,25-dihydroxyvita-
min D3 showed no or little induction (Fig 2). 
Because mRNA isolated from skin biopsies used in this study is 
approximately 95% derived from keratinocytes [26], the majority of 
RA-induced Egr-l seen il1 vivo (Fig 3) is unlikely to be explai.t!ed by 
the presence of mRNA derived from dermal fibroblasts. This is in 
contrast to the only slight increase in Egr-l transcripts observed 
after treatment with RA in subconfluent cultures ofkeratinocytes ill 
lIitro (Fig 1). However, a similar effect of RA on cellular retinoic 
acid binding protein-II mRNA levels in human skin itlv ivo and cul-
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tured human keratinocytes has been observed [27]. When compar-
ing the results of an in vitro nuclear transcription assay with whole 
preosteoblastic cells, Suva et al [24] suggested that the more pro-
nounced stimulation of Egr-l transcript by RA observed ill vivo 
could be due to RNA accumulation as a result of mRNA stabiliza-
tion. RA regulation of gene expression is known to occur at both the 
transcriptional [31,32] and posttranscriptional [33] levels. Thus, the 
persistent increase ofEgr-1 mRNA produced by RA for up to 24 and 
48 h in human skin ill vivo could be due to an increased transcription 
rate of the gene, stabilization of the newly synthesized mRNA 
transcripts, or a combination of both. The returnal of Egr- l tran-
scripts to a nearly basal level by 96 h (mean 1.30) is consistent with 
the possibility that this early growth response transcription factor 
may serve to activate transcription of other genes whose products 
give rise to the alterations in cell phenotype after stimulation with 
RA [23,24]. 
Whether RA induction of the human Egr-1 gene occurs at the 
level of transcription and whether this regulation is mediated by 
retinoic acid receptors remains to be investigated. However, because 
Egr-1 is a transcription factor able to specifically bind genomic 
DNA and potentially activate target gene expression, further studies 
of Egr-1 in human skin may provide insights into the molecular 
mechanisms of the genetic events leading to the altered differentia-
tion program. 
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